These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31129660)

  • 1. Poor Prognosis of Advanced Cholangiocarcinoma: Real-World Data from a Tertiary Referral Center.
    Koch C; Franzke C; Bechstein WO; Schnitzbauer AA; Filmann N; Vogl T; Gruber-Rouh T; Zeuzem S; Waidmann O; Trojan J
    Digestion; 2020; 101(4):458-465. PubMed ID: 31129660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution.
    Burger I; Hong K; Schulick R; Georgiades C; Thuluvath P; Choti M; Kamel I; Geschwind JF
    J Vasc Interv Radiol; 2005 Mar; 16(3):353-61. PubMed ID: 15758131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results.
    Aliberti C; Benea G; Tilli M; Fiorentini G
    Cardiovasc Intervent Radiol; 2008; 31(5):883-8. PubMed ID: 18478290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success.
    Vogl TJ; Naguib NN; Nour-Eldin NE; Bechstein WO; Zeuzem S; Trojan J; Gruber-Rouh T
    Int J Cancer; 2012 Aug; 131(3):733-40. PubMed ID: 21976289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma.
    Herber S; Otto G; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann A; Thies J; Düber C; Pitton M
    Cardiovasc Intervent Radiol; 2007; 30(6):1156-65. PubMed ID: 17508242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma.
    Strand DS; Cosgrove ND; Patrie JT; Cox DG; Bauer TW; Adams RB; Mann JA; Sauer BG; Shami VM; Wang AY
    Gastrointest Endosc; 2014 Nov; 80(5):794-804. PubMed ID: 24836747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma.
    Park SY; Kim JH; Yoon HJ; Lee IS; Yoon HK; Kim KP
    Clin Radiol; 2011 Apr; 66(4):322-8. PubMed ID: 21356394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study.
    Strijker M; Belkouz A; van der Geest LG; van Gulik TM; van Hooft JE; de Meijer VE; Haj Mohammad N; de Reuver PR; Verheij J; de Vos-Geelen J; Wilmink JW; Groot Koerkamp B; Klümpen HJ; Besselink MG;
    Acta Oncol; 2019 Jul; 58(7):1048-1055. PubMed ID: 30907207
    [No Abstract]   [Full Text] [Related]  

  • 10. Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogram.
    Ge Y; Jeong S; Luo GJ; Ren YB; Zhang BH; Zhang YJ; Shen F; Cheng QB; Sui CJ; Wang HY; Xia Q; Chen L
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):138-146. PubMed ID: 32139295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma.
    Poggi G; Amatu A; Montagna B; Quaretti P; Minoia C; Sottani C; Villani L; Tagliaferri B; Sottotetti F; Rossi O; Pozzi E; Zappoli F; Riccardi A; Bernardo G
    Cardiovasc Intervent Radiol; 2009 Nov; 32(6):1187-92. PubMed ID: 19727937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010-2016.
    Wang J; Bo X; Nan L; Wang CC; Gao Z; Suo T; Ni X; Liu H; Lu P; Wang Y; Liu H
    Cancer Med; 2020 Feb; 9(4):1335-1348. PubMed ID: 31876990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
    Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
    Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unresectable perihilar cholangiocarcinoma: multimodal palliative treatment.
    Mosconi C; Renzulli M; Giampalma E; Galuppi A; Balacchi C; Brandi G; Ercolani G; Bianchi G; Golfieri R
    Anticancer Res; 2013 Jun; 33(6):2747-53. PubMed ID: 23749936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoembolization with Drug-eluting Microspheres Loaded with Doxorubicin for the Treatment of Cholangiocarcinoma.
    Aliberti C; Carandina R; Sarti D; Pizzirani E; Ramondo G; Mulazzani L; Mattioli GM; Fiorentini G
    Anticancer Res; 2017 Apr; 37(4):1859-1863. PubMed ID: 28373452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study.
    Kiefer MV; Albert M; McNally M; Robertson M; Sun W; Fraker D; Olthoff K; Christians K; Pappas S; Rilling W; Soulen MC
    Cancer; 2011 Apr; 117(7):1498-505. PubMed ID: 21425151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
    Na SK; Choi GH; Lee HC; Shin YM; An J; Lee D; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS
    PLoS One; 2018; 13(6):e0198138. PubMed ID: 29879137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes.
    Kim JH; Yoon HK; Sung KB; Ko GY; Gwon DI; Shin JH; Song HY
    Cancer; 2008 Oct; 113(7):1614-22. PubMed ID: 18704990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of cholangiocarcinoma patients in northeastern Thailand after supportive treatment.
    Thunyaharn N; Promthet S; Wiangnon S; Suwanrungruang K; Kamsa-ard S
    Asian Pac J Cancer Prev; 2013; 14(11):7029-32. PubMed ID: 24377644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.